| abstract |
In various aspects, the present invention provides methods, compositions, medications, and dosing schedules for treating autoimmune diseases, including systemic lupus erythematosus (SLE), for patients in need of such treatment. Administering a TACI-Ig fusion molecule such as. In one aspect, the TACI-Ig fusion molecule is administered in an amount sufficient to slow, suppress, or inhibit the function of inducing the proliferation of BLyS and APRIL, particularly relatively low throughout the course of treatment. It relates to the use of multiple doses of the fusion molecule at a dosage. |